[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2009/7751,2009,A2Locationinpatent:Page/Pagecolumn103
[1]Patent:US2016/16951,2016,A1.Locationinpatent:Paragraph0277;0278
916792-28-4
191980-64-0
857531-32-9
874219-42-8 | 3-(Cyclohexylcarbamoyl)-5-fluorophenylboronic acid | AA004MV7 | MFCD08235059
869943-44-2 | [1-(4-Piperidin-1-ylphenyl)ethyl]amine | AA004NTK | MFCD04970996
847818-56-8 | 1-Ethylpyrazole-4-boronic acid | AA004OJL | MFCD10703521
860648-93-7 | 2-Pyrimidinamine,4-methyl-6-[(4-methylphenyl)sulfonyl]- | AA004P6D | MFCD00245874
87266-37-3 | 1H-Imidazole-1-acetic acid mono, HCl | AA004PU5 | MFCD00050629
864754-21-2 | 1-(Pyridin-3-ylmethyl)-1H-pyrazole-4-boronic acid, pinacol ester | AA004QMV | MFCD08706029
875551-59-0 | (S)-tert-Butyl (morpholin-2-ylmethyl)carbamate | AA004RIY | MFCD12545849
84449-80-9 | 4-(2-Piperidinoethoxy)benzoic acid, HCl | AA004SD6 | MFCD06657755
83725-78-4 | 5-(4-Methylphenyl)-3H-1,3,4-oxadiazol-2-one | AA004T3B | MFCD11046713
871333-04-9 | 4-(Ethyl(methyl)carbamoyl)phenylboronic acid | AA004TSI | MFCD08056368